Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Reata Lays Commercial Path For Skyclarys With First-Ever Friedreich’s Ataxia Nod
Mar 01 2023
•
By
Alaric DeArment
The FDA approved Skyclarys, the first drug for Friedreich's ataxia • Source: Shutterstock
More from New Products
More from Scrip